About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Sep 17, 2014...
Sugary sodas have come under fire for contributing to obesity and diabetes, but new research suggests artificial sweeteners may also raise blood sugar levels. Photograph by Sam Hodgson, Reuters
There's no such thing as a free lunch, or at least a free artificially sweetened one, a new study suggests. Saccharin and other artificial sweeteners may raise blood sugar levels – a condition the sugar substitutes aim to help prevent – by altering digestive bacteria, Israeli researchers reported on Wednesday. (Related: "What Lives in Your Gut?")
https://www.weizmann-usa.org/news-media/news-releases/rare-disorder-found-to-have-a-common-form/
Jun 17, 2015... A hereditary autoimmune disease that was thought to be exceedingly rare may have a less severe form that affects one in 1,000 people or even more, according to new research conducted at the Weizmann Institute of Science in Israel and the University of Bergen in Norway. The results of this research, which appeared June 15 in Immunity, suggest that a number of different autoimmune diseases and syndromes may be tied to mutations in a single gene. Among other things, these findings, combined with other research in the Weizmann lab, may help provide new means of diagnosing and treating autoimmune disorders.
https://www.weizmann-usa.org/news-media/in-the-news/coming-soon-a-vaccine-against-cancer/
Apr 17, 2011...
Holding out hope of a vaccine for some of today's deadliest diseases — Vacciguard CEO Dr. Anat Eitan.
The notion of a vaccine for cancer—or for many other deadly diseases nearly impossible to control, let alone cure—may seem to be no more than wishful thinking. But that is exactly what Israeli biomed startup Vacciguard is introducing: A technology tool for developing vaccines against a wide range of diseases from cancer to West Nile virus.
Sep 27, 2019...
JERUSALEM, Sept. 26 (Xinhua) – New discovery of bacteria immune system brought insight into treating autoimmune disease and even cancer, the Weizmann Institute of Science in Israel reported Thursday.
Israeli researchers found that humans and bacteria have the same defense mechanism in the immune system, and bacteria must continually protect themselves from viruses called phages that infect them, the report said.
Nov 30, 2017... Toward Healthy Aging: The Sagol Institute of Longevity
May 11, 2020... Researchers in Israel have succeeded in determining the biological processes that characterize seriously ill COVID-19 patients, as compared to those who are only mildly affected. The researchers, headed by Prof. Ido Amit from the Department of Immunology at the Weizmann Institute of Science in Rehovot, examined the differences between those who were seriously ill and lightly ill. They based their analysis partly on the virus’ activity at the single cell level.
May 14, 2020...
Throughout the COVID-19 outbreak, one of the greatest mysteries to confound researchers has been figuring out why the disease leaves some people almost completely unharmed, while others suffer serious conditions and die.
The answer, according to Israeli scientists, is that lungs of the worst-affected patients become riddled with immune cells that exacerbate the pathogen’s impact instead of fighting it. In patients who are less affected by the disease, this doesn’t happen, says the team from the Weizmann Institute of Science.
May 17, 2020...
An immune system run amok may be responsible for some Covid-19 patients faring worse than others, suggests a new international study led by immunology researchers at Israel’s Weizmann Institute of Science.
Published in the journal Cell on May 7, “Host-viral infection maps reveal signatures of severe COVID-19 patients,” researchers in the lab of Prof. Ido Amit introduce Viral-Track, a computational method they have validated to systematically detect viruses from multiple models of infection.
Apr 06, 2020...
A comprehensive review of published studies on gut microbiota, immunity and arthritis suggests that having a microbial imbalance may precede the development of spondyloarthritides and osteoarthritis.
The review, which was published in Seminars in Arthritis and Rheumatism, suggests a close connection between an impaired microbiota, the immune system and inflammatory arthritis.
“In this review, we presented data supporting the idea that dysbiosis via a close, dynamic and tightly regulated cross talk with gut-associated lymphoid tissue, governs the development of inflammatory arthropathies, such as rheumatoid arthritis, spondyloarthritis and osteoarthritis. It became clear that unfavorable dysbiosis-mediated immune alterations precede the development of these disorders suggesting causal relationships in this link,” wrote authors Alexander Kalinkovich of the Weizmann Institute of Science in Israel, and Gregory Livshits of Tel Aviv University.
Apr 27, 2020... On May 2, 1986, while visiting my long-term colleague and friend Richard O’Reilly, the head of bone marrow transplantation at Memorial Sloan Kettering Cancer Center in New York, I received a strange phone call. It was from Richard Champlin, who worked at the Bone Marrow Transplant Center at UCLA. He tended to speak very fast, so it took me some time to understand from his over-excited voice that he was about to leave the next day for Moscow.
©2023 American Committee for the Weizmann Institute of Science
